ZPD A/S: Financial statements 2018
CVR: 32834825
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ZPD A/S (CVR 32834825) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 41,504,000 and a net result of DKK 11,439,000 compared with DKK 11,178,000 the year before. That is an increase of 1.8% compared with the year before. Equity in the 2018 report amounted to DKK 157,544,000. The solvency ratio was 92.7%. The company had 32 employees in the financial year.
- Gross Profit
- DKK 41,504,000
- Profit/Loss
- DKK 11,439,000
- Equity
- DKK 157,544,000
- Total Assets
- DKK 169,876,000
- Employees
- 32
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 41.5 mio. | 11.4 mio. | 157.5 mio. | 32 |
| 2017 | - | 40.8 mio. | 11.2 mio. | 146.1 mio. | 28 |
| 2016 | - | 39.8 mio. | 10.9 mio. | 134.9 mio. | 28 |
| 2015 | - | 47.8 mio. | 19.8 mio. | 124 mio. | 27 |
| 2014 | - | 45.2 mio. | 17 mio. | 110.2 mio. | 28 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of May 28, 2018, Hiroki Kato has joined the board of directors of ZPD A/S.
As of May 28, 2018, Makoto Kishimoto has left the board of directors of ZPD A/S.
ZPD A/S has published its annual report for 2017. Gross profit came to DKK 40,790,000, and the net result was DKK 11,178,000.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.